Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
Tongji University · Shanghai Pulmonary Hospital · +37 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
501
total citations
- FWCI
- 24.98
- Percentile
- 100%
- References
- 27
Citations per year
Authors
36- CZCaicun ZhouCorresponding
Tongji University, Shanghai Pulmonary Hospital
- GCGongyan Chen
Harbin Medical University, Third Affiliated Hospital of Harbin Medical University
- YHYunchao Huang
Kunming Medical University
- JZJianying Zhou
First Affiliated Hospital Zhejiang University
- LLLizhu Lin
First Affiliated Hospital of Guangzhou University of Chinese Medicine
Topics & keywords
Topics
Keywords
- Pemetrexed
- Medicine
- Carboplatin
- Internal medicine
- Oncology
- Lung cancer
- Chemotherapy
- Response Evaluation Criteria in Solid Tumors
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.